ReviewPublic health in practice (Oxford, England)2025
Cost-utility tele-stroke in adults with acute ischemic stroke. A systematic review.
Review in Public health in practice (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cost-effectiveness analysis of a telemedicine network for acute neurological care in northeast Germany (ANNOTeM).Frontiers in digital health · 2026Article
- Reply to: "Telemedicine for stroke: a Brazilian success story".Arquivos de neuro-psiquiatria · 2025Article
- Natural language processing for triage of cerebral large-vessel occlusion.Arquivos de neuro-psiquiatria · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tele-Stroke has been proposed as a solution to increase access to thrombolytic therapy in acute ischemic stroke. Methods: Systematic review of cost-effectiveness economic evaluations of Tele-Stroke from the Centre for Reviews and Dissemination of the University of York, International HTA Database, PubMed, EMBASE, Cochrane Library, Cost-Effectiveness Analysis Registry, National Institute for Health and Care Excellence, The European Network of Health Economic Evaluation Databases Project and grey literature. Quality assessment, data selection and data extraction were performed by two reviewers. A qualitative synthesis was conducted. Results: Twelve studies, published between 2008 and 2022 in high-income countries were included; 50.00 % were conducted from a health system perspective and the most frequent discount rate was 3 %. Spoke/Hub ratio ranged from 1:1 to 17:2. In 5/12 studies Tele-Stroke was found to be highly cost-effective (dominant intervention: lower cost and higher effectiveness) and only two acceptable (lower cost and lower effectiveness). Incremental Cost Effectiveness Ratio (ICER) per Quality-Adjusted Life Years (QALY) gained ranged from US$ 290,368.77 to US$ 327.44 in 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.